{
    "id": 80147,
    "name": "lymphoblastic lymphoma",
    "source": "DOID",
    "definition": "A lymphoma that has_material_basis_in immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage and located_in primarily lymph nodes or located_in extranodal sites. [url:https\\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=14.10d&code=C7055]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:0080147",
    "evidence": [
        {
            "id": 9496,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Imbruvica (ibrutinib) and VLX1570 worked synergistically to reduce viability of an Imbruvica (ibrutinib)-resistant Waldenstrom macroglobulinemia cell line in culture (PMID: 27813535).",
            "molecularProfile": {
                "id": 17605,
                "profileName": "Unknown unknown"
            },
            "therapy": {
                "id": 5040,
                "therapyName": "Ibrutinib + VLX1570",
                "synonyms": null
            },
            "indication": {
                "id": 80147,
                "name": "lymphoblastic lymphoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 7224,
                    "pubMedId": 27813535,
                    "title": "Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27813535"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 19119,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "BCR-ABL1 aids in the diagnosis of lymphoblastic lymphoma (NCCN.org).",
            "molecularProfile": {
                "id": 2513,
                "profileName": "BCR - ABL1"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 80147,
                "name": "lymphoblastic lymphoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT00501826",
            "title": "Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8387,
                    "therapyName": "Nelarabine + Pegaspargase + Venetoclax",
                    "synonyms": null
                },
                {
                    "id": 8366,
                    "therapyName": "Cyclophosphamide + Dexamethasone + Doxorubicin + Nelarabine + Pegaspargase + Venetoclax + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8363,
                    "therapyName": "Mercaptopurine + Methotrexate + Prednisone + Venetoclax + Vincristine",
                    "synonyms": "POMP + Venetoclax"
                },
                {
                    "id": 8365,
                    "therapyName": "Cytarabine + Methotrexate + Nelarabine + Pegaspargase + Venetoclax",
                    "synonyms": null
                },
                {
                    "id": 8364,
                    "therapyName": "Methotrexate + Pegaspargase + Venetoclax",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT01658007",
            "title": "Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma",
            "phase": "Phase I",
            "recruitment": "Terminated",
            "therapies": [
                {
                    "id": 917,
                    "therapyName": "Sirolimus",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02112916",
            "title": "Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma",
            "phase": "Phase III",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 1148,
                    "therapyName": "Cyclophosphamide",
                    "synonyms": null
                },
                {
                    "id": 1631,
                    "therapyName": "Vincristine",
                    "synonyms": null
                },
                {
                    "id": 1441,
                    "therapyName": "Ifosfamide",
                    "synonyms": null
                },
                {
                    "id": 1638,
                    "therapyName": "Pegaspargase",
                    "synonyms": null
                },
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 712,
                    "therapyName": "Cytarabine",
                    "synonyms": null
                },
                {
                    "id": 1640,
                    "therapyName": "Mercaptopurine",
                    "synonyms": null
                },
                {
                    "id": 1641,
                    "therapyName": "Thioguanine",
                    "synonyms": null
                },
                {
                    "id": 1642,
                    "therapyName": "Leucovorin",
                    "synonyms": null
                },
                {
                    "id": 1006,
                    "therapyName": "Daunorubicin",
                    "synonyms": null
                },
                {
                    "id": 1390,
                    "therapyName": "Dexamethasone",
                    "synonyms": null
                },
                {
                    "id": 688,
                    "therapyName": "Bortezomib",
                    "synonyms": null
                },
                {
                    "id": 1136,
                    "therapyName": "Etoposide",
                    "synonyms": null
                },
                {
                    "id": 1009,
                    "therapyName": "Doxorubicin",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02793544",
            "title": "HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide",
            "phase": "Phase II",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 1148,
                    "therapyName": "Cyclophosphamide",
                    "synonyms": null
                },
                {
                    "id": 1206,
                    "therapyName": "Busulfan",
                    "synonyms": null
                },
                {
                    "id": 917,
                    "therapyName": "Sirolimus",
                    "synonyms": null
                },
                {
                    "id": 1845,
                    "therapyName": "Mycophenolate mofetil",
                    "synonyms": null
                },
                {
                    "id": 5682,
                    "therapyName": "Mesna",
                    "synonyms": null
                },
                {
                    "id": 1166,
                    "therapyName": "Fludarabine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02877303",
            "title": "Blinatumomab and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 9108,
                    "therapyName": "Blinatumomab + Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 9109,
                    "therapyName": "Blinatumomab + Mercaptopurine + Methotrexate + Prednisone + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 9110,
                    "therapyName": "Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Methotrexate + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 9111,
                    "therapyName": "Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Methotrexate + Ofatumumab + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 9112,
                    "therapyName": "Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Methotrexate + Rituximab + Vincristine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02879643",
            "title": "Vincristine Sulfate Liposome Injection (Marqibo) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8063,
                    "therapyName": "Dexamethasone + Methotrexate + Pegaspargase + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8064,
                    "therapyName": "Dexamethasone + Mercaptopurine + Methotrexate + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8062,
                    "therapyName": "Dexamethasone + Methotrexate + Mitoxantrone + Pegaspargase + Vincristine sulfate liposome",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02906371",
            "title": "Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome",
            "phase": "Phase I",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 5647,
                    "therapyName": "Tocilizumab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03023046",
            "title": "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 897,
                    "therapyName": "Rituximab",
                    "synonyms": null
                },
                {
                    "id": 1009,
                    "therapyName": "Doxorubicin",
                    "synonyms": null
                },
                {
                    "id": 1136,
                    "therapyName": "Etoposide",
                    "synonyms": null
                },
                {
                    "id": 770,
                    "therapyName": "Imatinib",
                    "synonyms": null
                },
                {
                    "id": 717,
                    "therapyName": "Dasatinib",
                    "synonyms": null
                },
                {
                    "id": 1148,
                    "therapyName": "Cyclophosphamide",
                    "synonyms": null
                },
                {
                    "id": 2188,
                    "therapyName": "Prednisone",
                    "synonyms": null
                },
                {
                    "id": 1631,
                    "therapyName": "Vincristine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03117751",
            "title": "Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1148,
                    "therapyName": "Cyclophosphamide",
                    "synonyms": null
                },
                {
                    "id": 1631,
                    "therapyName": "Vincristine",
                    "synonyms": null
                },
                {
                    "id": 1022,
                    "therapyName": "Idarubicin",
                    "synonyms": null
                },
                {
                    "id": 1876,
                    "therapyName": "Blinatumomab",
                    "synonyms": null
                },
                {
                    "id": 1009,
                    "therapyName": "Doxorubicin",
                    "synonyms": null
                },
                {
                    "id": 1746,
                    "therapyName": "Clofarabine",
                    "synonyms": null
                },
                {
                    "id": 1077,
                    "therapyName": "Vorinostat",
                    "synonyms": null
                },
                {
                    "id": 907,
                    "therapyName": "Ruxolitinib",
                    "synonyms": null
                },
                {
                    "id": 2188,
                    "therapyName": "Prednisone",
                    "synonyms": null
                },
                {
                    "id": 688,
                    "therapyName": "Bortezomib",
                    "synonyms": null
                },
                {
                    "id": 1136,
                    "therapyName": "Etoposide",
                    "synonyms": null
                },
                {
                    "id": 717,
                    "therapyName": "Dasatinib",
                    "synonyms": null
                },
                {
                    "id": 1006,
                    "therapyName": "Daunorubicin",
                    "synonyms": null
                },
                {
                    "id": 1390,
                    "therapyName": "Dexamethasone",
                    "synonyms": null
                },
                {
                    "id": 897,
                    "therapyName": "Rituximab",
                    "synonyms": null
                },
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 712,
                    "therapyName": "Cytarabine",
                    "synonyms": null
                },
                {
                    "id": 1640,
                    "therapyName": "Mercaptopurine",
                    "synonyms": null
                },
                {
                    "id": 1638,
                    "therapyName": "Pegaspargase",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03136146",
            "title": "Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1148,
                    "therapyName": "Cyclophosphamide",
                    "synonyms": null
                },
                {
                    "id": 688,
                    "therapyName": "Bortezomib",
                    "synonyms": null
                },
                {
                    "id": 1136,
                    "therapyName": "Etoposide",
                    "synonyms": null
                },
                {
                    "id": 897,
                    "therapyName": "Rituximab",
                    "synonyms": null
                },
                {
                    "id": 1090,
                    "therapyName": "Ofatumumab",
                    "synonyms": null
                },
                {
                    "id": 1746,
                    "therapyName": "Clofarabine",
                    "synonyms": null
                },
                {
                    "id": 1476,
                    "therapyName": "Pegfilgrastim",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03328104",
            "title": "AflacLL1602 ENCERT",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8014,
                    "therapyName": "Cyclophosphamide + Etoposide + Everolimus + Nelarabine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03349281",
            "title": "Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 6638,
                    "therapyName": "Dexamethasone + Doxorubicin + MLN4924 + Pegaspargase + Vincristine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03792256",
            "title": "Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8175,
                    "therapyName": "Cytarabine + Hydrocortisone + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8217,
                    "therapyName": "Cytarabine + Doxorubicin + Palbociclib + Pegaspargase + Prednisone + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8218,
                    "therapyName": "Cytarabine + Doxorubicin + Palbociclib + Pegaspargase + Prednisolone + Vincristine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03914625",
            "title": "Blinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed, Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic Lymphoma",
            "phase": "Phase III",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8540,
                    "therapyName": "Cytarabine + Leucovorin + Methotrexate + Pegaspargase + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8543,
                    "therapyName": "Blinatumomab + Dexamethasone + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8542,
                    "therapyName": "Leucovorin + Mercaptopurine + Methotrexate + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8545,
                    "therapyName": "Blinatumomab + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 1824,
                    "therapyName": "Mercaptopurine + Methotrexate + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8544,
                    "therapyName": "Blinatumomab + Dexamethasone + Leucovorin + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8547,
                    "therapyName": "Methotrexate + Pegaspargase + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8546,
                    "therapyName": "Blinatumomab + Leucovorin + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8549,
                    "therapyName": "Blinatumomab + Dexamethasone + Leucovorin",
                    "synonyms": null
                },
                {
                    "id": 8548,
                    "therapyName": "Mercaptopurine + Methotrexate + Prednisolone + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8550,
                    "therapyName": "Dexamethasone + Doxorubicin + Methotrexate + Pegaspargase + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8552,
                    "therapyName": "Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Leucovorin + Methotrexate + Pegaspargase + Thioguanine + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8555,
                    "therapyName": "Cyclophosphamide + Cytarabine + Mercaptopurine + Methotrexate + Pegaspargase + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8554,
                    "therapyName": "Cyclophosphamide + Cytarabine + Leucovorin + Mercaptopurine + Methotrexate + Pegaspargase + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8535,
                    "therapyName": "Leucovorin + Methotrexate + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8534,
                    "therapyName": "Methotrexate + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8537,
                    "therapyName": "Dexamethasone + Mercaptopurine + Methotrexate + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8536,
                    "therapyName": "Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Methotrexate + Pegaspargase + Thioguanine + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8539,
                    "therapyName": "Cytarabine + Dexamethasone + Methotrexate + Pegaspargase + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 3194,
                    "therapyName": "Mercaptopurine + Methotrexate + Prednisone + Vincristine",
                    "synonyms": "POMP"
                },
                {
                    "id": 8538,
                    "therapyName": "Dexamethasone + Leucovorin + Mercaptopurine + Methotrexate + Vincristine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03962465",
            "title": "Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL (ALL 001)",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8400,
                    "therapyName": "Daunorubicin + inotuzumab ozogamicin + Pegaspargase + Prednisone + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8399,
                    "therapyName": "Daunorubicin + inotuzumab ozogamicin + Prednisone + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 712,
                    "therapyName": "Cytarabine",
                    "synonyms": null
                },
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT04145531",
            "title": "An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 9207,
                    "therapyName": "JZP-458",
                    "synonyms": null
                }
            ]
        }
    ]
}